Seventeen years ago this month, The Spectator quoted a consultant who predicted it would take decades for Hamilton to develop a bioscience technology sector, due to a lack of available land, and because companies weren’t knocking down the city’s door to be “anchor tenants.” But news out of McMaster Innovation Park suggests it’s anchors aweigh […]
A research team at McMaster University has developed a self-cleaning surface that instantly repels viruses and bacteria – and could potentially prevent the transfer of superbugs (strains of bacteria resistant to most antibiotics). The transparent flexible film can be shrink-wrapped to fit onto door handles, railings, and other surfaces that act as magnets for bacteria. […]
Nov-2020
Hamilton-based packaging manufacturer and supplier HT Productions Inc. will receive $3.9 million in federal funding that will create nearly 50 new skilled jobs in the city. Speaking to The Spectator on Monday, Economic Development Minister Mélanie Joly said the company will be able to expand its facility and “adopt a more customer-centric online system” with […]
Israel-based Isotopia Molecular Imaging and CPDC (Hamilton, Ontario) are pleased to announce that they have entered into an agreement for the production and distribution of no-carrier-added Lutetium-177 (n.c.a. Lu-177), a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for treatment of many types of cancer, including neuroendocrine tumors and prostate cancer. The Centre for […]
Fusion Pharmaceuticals Inc., a Hamilton, Ontario-based clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced a collaboration with AstraZeneca to develop and commercialize next-generation alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. The collaboration leverages Fusion’s Targeted Alpha Therapies (TATs) platform and expertise in radiopharmaceuticals with AstraZeneca’s leading portfolio […]
Bay Area Health Trust (bayareahealthtrust.com), is a Hamilton based company that operates businesses in the life sciences and seeks strategic opportunities in new technologies in the health and life science fields. VoxNeuro (voxneuro.com) has been dubbed as one of Hamilton’s “startups to watch” from leaders across the industry. For Bay Area Health Trust, whose goal […]
A Hamilton Health Sciences team has developed an innovative smartphone application that will soon help patients manage the effects of concussions on their daily lives. The MyHeadHealth mobile app will provide concussion patients with a personalized treatment plan, instructional videos, educational tools and a way for them to input information on their health and symptoms. […]
Sep-2020
Bay Area Health Trust (www.bayareahealthtrust.com), a Hamilton, Ontario based company today announced an exclusive licensing agreement for the ‘McMaster Molecular Medium (“MMM”) with McMaster University. Developed by researchers from St. Joseph’s Healthcare Hamilton‘s Disease Diagnostics and Development Group, MMM will enable labs to safely increase their COVID testing capacity and therefore return results faster. In […]
Sep-2020
n the hopes of averting future pandemics, Hamilton’s McMaster University is connecting a number of its top infectious disease clinicians and researchers worldwide to prevent global health threats like antimicrobial resistance. The goal of the Global Nexus for Pandemics and Biological Threats is to ensure Canada and the world are better able to manage the […]
Aug-2020
Triumvira Immunologics Inc. (“Triumvira”), a privately-held biopharmaceutical company developing a novel platform for engineering T-cells to attack cancers, successfully completed a USD $55 million Series A financing round. The financing was co-led by Leaps by Bayer, the impact investment unit of Bayer AG, and Northpond Ventures. Additional investors include Oceanpine Capital and Viva Biotech Holdings, […]